PUTNAM INVESTMENTS LLC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 487 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2014. The put-call ratio across all filers is 0.91 and the average weighting 1.2%.

Quarter-by-quarter ownership
PUTNAM INVESTMENTS LLC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q3 2015$7,407,000
-20.3%
41,526
-0.7%
0.02%
-10.5%
Q2 2015$9,292,000
-43.9%
41,826
-49.9%
0.02%
-42.4%
Q1 2015$16,575,000
+34.7%
83,452
-2.9%
0.03%
+32.0%
Q4 2014$12,304,000
-38.8%
85,977
-43.9%
0.02%
-41.9%
Q3 2014$20,107,000
+41.2%
153,255
+35.7%
0.04%
+38.7%
Q2 2014$14,245,000
+2976.7%
112,943
+2765.1%
0.03%
+3000.0%
Q4 2013$463,000
+12.7%
3,9420.0%0.00%0.0%
Q3 2013$411,000
-92.6%
3,942
-93.9%
0.00%
-93.8%
Q2 2013$5,518,00064,0990.02%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q2 2014
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders